trending Market Intelligence /marketintelligence/en/news-insights/trending/IYmY5vNMS7oqgj4KqJf5dg2 content esgSubNav
In This List

Proteostasis CFO resigns

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Proteostasis CFO resigns

Proteostasis Therapeutics Inc. CFO James DeTore will leave the company, effective Feb. 10, for personal reasons.

Brett Hagen, the company's controller and principal accounting officer, will assume certain of DeTore's duties on an interim basis, while Proteostasis searches for a permanent CFO.

Hagen previously served as a controller for BIND Therapeutics Inc.